These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 15561602

  • 1. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
    Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D.
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):457-75. PubMed ID: 15561602
    [Abstract] [Full Text] [Related]

  • 2. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [Abstract] [Full Text] [Related]

  • 3. [New paradigms in the regulation of bone metabolism].
    Rosa-Rañal M, de la Cruz DA, Lorena-Rubio Y, Larrea F.
    Rev Invest Clin; 2001 Jun; 53(4):362-9. PubMed ID: 11599485
    [Abstract] [Full Text] [Related]

  • 4. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 5. Key roles of the OPG-RANK-RANKL system in bone oncology.
    Baud'huin M, Duplomb L, Ruiz Velasco C, Fortun Y, Heymann D, Padrines M.
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):221-32. PubMed ID: 17288531
    [Abstract] [Full Text] [Related]

  • 6. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S, Kwan Tat S, Vusio P, Blanchard F, Gallagher J, Ricard-Blum S, Fortun Y, Padrines M, Rédini F, Heymann D.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):460-7. PubMed ID: 16828054
    [Abstract] [Full Text] [Related]

  • 7. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.
    Hofbauer LC, Kluger S, Kühne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE.
    J Cell Biochem; 2002 Aug 25; 86(4):642-50. PubMed ID: 12210731
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of RANK ligand involved in bone metabolism.
    Ito S, Hata T.
    Vitam Horm; 2004 Aug 25; 67():19-33. PubMed ID: 15110169
    [Abstract] [Full Text] [Related]

  • 9. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.
    Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM.
    J Bone Miner Res; 2001 Jun 25; 16(6):1015-27. PubMed ID: 11393778
    [Abstract] [Full Text] [Related]

  • 10. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM, Pearse RN.
    Cancer; 2003 Feb 01; 97(3 Suppl):802-12. PubMed ID: 12548579
    [Abstract] [Full Text] [Related]

  • 11. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption.
    Aubin JE, Bonnelye E.
    Medscape Womens Health; 2000 Mar 01; 5(2):5. PubMed ID: 10792853
    [Abstract] [Full Text] [Related]

  • 12. RANKL-RANK signaling in osteoclastogenesis and bone disease.
    Wada T, Nakashima T, Hiroshi N, Penninger JM.
    Trends Mol Med; 2006 Jan 01; 12(1):17-25. PubMed ID: 16356770
    [Abstract] [Full Text] [Related]

  • 13. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
    Lossdörfer S, Schwartz Z, Wang L, Lohmann CH, Turner JD, Wieland M, Cochran DL, Boyan BD.
    J Biomed Mater Res A; 2004 Sep 01; 70(3):361-9. PubMed ID: 15293309
    [Abstract] [Full Text] [Related]

  • 14. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
    Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT.
    J Rheumatol; 2005 Apr 01; 32(4):713-20. PubMed ID: 15801030
    [Abstract] [Full Text] [Related]

  • 15. Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease.
    Sattler AM, Schoppet M, Schaefer JR, Hofbauer LC.
    Calcif Tissue Int; 2004 Jan 01; 74(1):103-6. PubMed ID: 14523602
    [Abstract] [Full Text] [Related]

  • 16. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation.
    Fábrega E, Orive A, García-Unzueta M, Amado JA, Casafont F, Pons-Romero F.
    Clin Transplant; 2006 Jan 01; 20(3):383-8. PubMed ID: 16824158
    [Abstract] [Full Text] [Related]

  • 17. The OPG/RANKL/RANK system in metabolic bone diseases.
    Hofbauer LC, Kühne CA, Viereck V.
    J Musculoskelet Neuronal Interact; 2004 Sep 01; 4(3):268-75. PubMed ID: 15615494
    [Abstract] [Full Text] [Related]

  • 18. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.
    J Endocrinol; 2005 Jun 01; 185(3):401-13. PubMed ID: 15930166
    [Abstract] [Full Text] [Related]

  • 19. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P.
    Circ Res; 2004 Nov 26; 95(11):1046-57. PubMed ID: 15564564
    [Abstract] [Full Text] [Related]

  • 20. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan 26; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.